Sinopharm Group Co. Ltd. (FRA:X2S)

Sinopharm Group Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	47,157	54,313	63,809	55,222	43,529	50,178
Short-Term Investments	-	3,172	3,330	3,199	2,812	2,633
Trading Asset Securities	0.13	0.16	0.55	0.5	11.75	39.14
Cash & Short-Term Investments	47,157	57,486	67,139	58,421	46,353	52,850
Cash Growth	8.83%	-14.38%	14.92%	26.04%	-12.29%	27.68%
Accounts Receivable	244,129	201,479	185,790	171,204	172,576	146,049
Other Receivables	7,384	5,248	4,007	3,703	3,698	3,399
Receivables	251,513	206,727	189,797	174,908	176,273	149,448
Inventory	65,520	62,353	60,028	60,926	51,500	47,085
Restricted Cash	-	1,328	1,850	1,488	-	-
Other Current Assets	9,707	19,554	18,022	23,665	16,796	18,226
Total Current Assets	373,897	347,448	336,835	319,406	290,922	267,610
Property, Plant & Equipment	15,897	19,632	19,898	19,647	19,408	18,896
Long-Term Investments	10,550	10,894	10,551	9,840	9,184	8,473
Goodwill	6,203	6,252	7,186	7,156	7,199	7,287
Other Intangible Assets	3,998	2,473	2,830	2,941	3,116	3,361
Long-Term Accounts Receivable	1,059	1,156	793.92	1,123	874.58	870
Long-Term Deferred Tax Assets	2,773	2,408	1,964	1,980	1,787	1,602
Long-Term Deferred Charges	1,298	224.01	180.02	74.44	76.61	81.26
Other Long-Term Assets	4,492	2,344	3,158	2,607	2,845	3,057
Total Assets	420,168	392,831	383,395	364,775	335,412	311,237
Accounts Payable	152,673	151,109	146,632	137,085	128,431	112,632
Accrued Expenses	1,655	8,123	8,832	9,571	8,354	7,760
Current Portion of Long-Term Debt	7,931	62,729	54,730	52,997	55,152	54,959
Current Portion of Leases	-	1,761	1,797	1,636	1,548	1,406
Current Income Taxes Payable	2,163	1,447	1,775	1,703	1,614	1,470
Current Unearned Revenue	6,741	6,829	6,399	10,396	6,086	7,324
Other Current Liabilities	30,637	18,377	21,326	21,574	18,122	18,426
Total Current Liabilities	279,782	250,376	241,491	234,963	219,307	203,977
Long-Term Debt	4,436	8,637	13,834	11,750	8,419	8,919
Long-Term Leases	2,945	3,259	3,421	3,207	3,250	3,243
Long-Term Unearned Revenue	404.11	413.86	448.24	493.85	462.74	453.87
Long-Term Deferred Tax Liabilities	660.37	638.75	788.38	936.74	1,023	1,112
Other Long-Term Liabilities	2,375	2,406	2,727	2,975	2,910	3,189
Total Liabilities	290,695	266,144	263,076	254,706	235,758	221,289
Common Stock	3,121	3,121	3,121	3,121	3,121	3,121
Additional Paid-In Capital	20,454	24,641	24,641	24,641	24,641	24,641
Retained Earnings	56,791	55,532	51,197	44,701	38,516	32,908
Treasury Stock	-3.84	-3.84	-3.84	-3.84	-3.84	-3.84
Comprehensive Income & Other	20.19	-4,407	-4,373	-4,391	-4,388	-4,308
Total Common Equity	80,382	78,884	74,582	68,069	61,886	56,359
Minority Interest	49,090	47,804	45,737	42,001	37,768	33,588
Shareholders' Equity	129,472	126,687	120,319	110,069	99,654	89,947
Total Liabilities & Equity	420,168	392,831	383,395	364,775	335,412	311,237
Total Debt	93,295	76,386	73,782	69,590	68,368	68,527
Net Cash (Debt)	-46,137	-18,900	-6,643	-11,169	-22,016	-15,677
Net Cash Per Share	-14.83	-6.06	-2.13	-3.58	-7.05	-5.04
Filing Date Shares Outstanding	3,121	3,121	3,121	3,121	3,121	3,121
Total Common Shares Outstanding	3,121	3,121	3,121	3,121	3,121	3,121
Working Capital	94,115	97,072	95,344	84,443	71,616	63,633
Book Value Per Share	25.76	25.28	23.90	21.81	19.83	18.06
Tangible Book Value	70,181	70,159	64,566	57,972	51,571	45,711
Tangible Book Value Per Share	22.49	22.48	20.69	18.58	16.53	14.65
Buildings	-	13,752	12,997	12,907	12,127	11,346
Machinery	-	10,728	10,099	9,169	8,412	7,605
Construction In Progress	-	739.81	505.47	800.05	718.53	519.85

Source: S&P Global Market Intelligence. Standard template. Financial Sources.